Addition of Contrast-enhanced Mammography to Tomosynthesis for Breast Cancer Detection in Women with a Personal History of Breast Cancer: Prospective TOCEM Trial Interim Analysis

Wendie A. Berg,Jeremy M. Berg,Andriy I. Bandos,Adrienne Vargo,Denise M. Chough,Amy H. Lu,Marie A. Ganott,Amy E. Kelly,Bronwyn E. Nair,Jamie Y. Hartman,Uzma Waheed,Christiane M. Hakim,Kimberly S. Harnist,Ruthane F. Reginella,Dilip D. Shinde,Bea A. Carlin,Cathy S. Cohen,Luisa P. Wallace,Jules H. Sumkin,Margarita L. Zuley
DOI: https://doi.org/10.1148/radiol.231991
IF: 19.7
2024-05-01
Radiology
Abstract:Background Digital breast tomosynthesis (DBT) is often inadequate for screening women with a personal history of breast cancer (PHBC). The ongoing prospective Tomosynthesis or Contrast-Enhanced Mammography, or TOCEM, trial includes three annual screenings with both DBT and contrast-enhanced mammography (CEM). Purpose To perform interim assessment of cancer yield, stage, and recall rate when CEM is added to DBT in women with PHBC. Materials and Methods From October 2019 to December 2022, two...
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?